Diep QN et al. |
Formation of pivaloylcarnitine in heart and brown adipose tissue in the rat. |
1995 |
Biochim. Biophys. Acta |
pmid:7827109
|
Diep QN and Bøhmer T |
Increased pivaloylcarnitine in the liver of the sodium pivalate treated rat exposed to clofibrate. |
1995 |
Biochim. Biophys. Acta |
pmid:7766704
|
Okudaira N et al. |
Up-regulation of carnitine transporters helps maintain tissue carnitine levels in carnitine deficiency induced by pivalic acid. |
2001 |
Pharm. Res. |
pmid:11451029
|
Brass EP |
Pivalate-generating prodrugs and carnitine homeostasis in man. |
2002 |
Pharmacol. Rev. |
pmid:12429869
|
Yamaguchi T et al. |
Possible mechanism for species difference on the toxicity of pivalic acid between dogs and rats. |
2006 |
Toxicol. Appl. Pharmacol. |
pmid:16430936
|
Okamura N et al. |
Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid. |
2006 |
Pharm. Res. |
pmid:16826461
|
Ohnishi S et al. |
Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment. |
2008 |
Drug Metab. Pharmacokinet. |
pmid:18762717
|
Todesco L et al. |
Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2. |
2009 |
Chem. Biol. Interact. |
pmid:19539806
|
Nakajima Y et al. |
Detection of pivaloylcarnitine in pediatric patients with hypocarnitinemia after long-term administration of pivalate-containing antibiotics. |
2010 |
Tohoku J. Exp. Med. |
pmid:20651467
|
Forni S et al. |
Rapid determination of C4-acylcarnitine and C5-acylcarnitine isomers in plasma and dried blood spots by UPLC-MS/MS as a second tier test following flow-injection MS/MS acylcarnitine profile analysis. |
2010 |
Mol. Genet. Metab. |
pmid:20591710
|